London Music Hall welcomes Art of Dying and Apocalyptica on the Shadowmaker Tour.

After taking some time off to recharge the batteries and make some new music, Art of Dying is back and hitting the road with a vengeance. A five-song EP Rise Up is available now, with a full new album coming later in the summer. So far this year, the Canadian boys have been busy hitting the summer festival circuit, including Rock on the Range, and will be continuing on with festival appearances into the fall when they will share the stage with Faith No More and the Deftones, among others. Mixed in with these festival dates, is the current tour with Apocalyptica, acting as support for their Shadowmaker Tour.

Art of Dying hit the stage in London, clearly on a mission. Front man, Jonny Hetherington, was like a pacing tiger, back and forth all over the stage. A pounding set, filled with crowd favorites like “Get Thru This” kept the crowd engaged from the get go. The set included the new single, “Rise Up,” which is already gaining momentum as a favorite based on the audience sing along through out. If fun, high energy rock ‘n roll is your thing, be sure to check out Art of Dying when they play in your area.

Apocalyptica, a Finnish cello-rock band, took the stage to close the night. Featuring a great mix of classical music and heavy rock, they are something to behold. There isn’t a guitar in sight, the band consists of three cellos, a drummer, and a vocalist on only a few songs, yet Apocalyptica will take you on a musical journey that really must be heard to be believed. Currently touring in support of their latest album, Shadowmaker, and hitting most of the festival circuit throughout North America and Europe, Apocalyptica is definitely leaving their mark wherever they go. If you get a chance to see them perform, you’ll become a fan for sure.

National Rock Review photographer Mark Skinner was on hand to capture the action.

Apocalyptica
Website | Facebook | Twitter

Art Of Dying
Website | Facebook | Twitter

London Music Hall
Website | Facebook | Twitter